Trials / Conditions / Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
3 registered clinical trials studyying Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML NCT06786533 | Hemogenyx Pharmaceuticals LLC | Phase 1 |
| Recruiting | Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia NCT06532058 | Changzhou Qianhong Bio-pharma Co., Ltd. | Phase 2 |
| Recruiting | A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia NCT05924750 | Sichuan Baili Pharmaceutical Co., Ltd. | Phase 1 |